By the time we had baby number two (and three), it was automatic. Anytime someone asked, “What kind of diapers do you need?,” ...

Earnings call Kimberly-Clark posted Q3 2025 organic sales growth of 2.5%, led by 2.4% volume gains, with strong performance in Baby and Child Care across key markets. Operating margins held steady ...

Kimberly-Clark Corp. (KMB) reported better-than-expected earnings for Q3 2025, with an EPS of $1.82, surpassing the forecast of $1.75. Revenue also exceeded expectations, reaching 4.15 billion dollars ...

Kimberly-Clark will buy Kenvue for $48.7 billion. Kenvue is the maker of Tylenol. Kenvue just beat earnings in its Q3 2025 report. The good news for Kenvue is that the bad press didn't prevent the ...